Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. has requested a trading halt for its securities pending an announcement regarding a capital raising. The halt will remain in effect until normal trading resumes or the announcement is released to the market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-413
EMvision Medical Devices Ltd. on 6ix
In the deck
Earlier from EMvision Medical Devices
- Appendix 4E & Annual Report to 30 June 2025
- UCLA Health Activation & Continuous Innovation Study Update
- EMVision Awarded $3m Grant For Regional Benefits Study
- First Responder Program Advanced & Grant Milestone Achieved
- Key Developments in Pivotal Trial & Innovation Study
Later from EMvision Medical Devices
- Firm Commitments for $12.0M Placement & Launch of SPP
- Pre-Hospital MSU Study Commences with First Responder Device
- SPP Offer Document & Option Prospectus
- $3m CRC-P Grant Executed & First Payment Received
- Oversubscribed SPP To Close Early
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices